Skip to content

Korn Ferry KFY Available-for-Sale Securities (Non-Current)

Available-for-Sale Securities (Non-Current) at other companies

Hubbell logo
HubbellHUBB
$99.8M+14.8%
Teradyne, Inc. logo
Teradyne, Inc.TER
$148.37M+30.4%
Royalty Pharma logo
Royalty PharmaRPRX
$406.8M+85.8%
HubSpot logo
HubSpotHUBS
$87.52M-50.4%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$0
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$1.33B+63.3%

Other financials

Income statement

See full
Revenue$725.0M+7.2%
Operating income$91.0M+16.3%
Net income$65.3M+11.7%
EPS (diluted)$1.23+11.8%

Balance sheet

See full
Cash & equivalents$938.4M+20.4%
Total debt$564.5M-0.6%
Total equity$2.0B+11.7%
Total assets$3.9B+8.2%

Cash flow

See full
Operating cash flow$233.5M+9.2%
CapEx$21.7M+25.0%
Free cash flow$211.7M+7.8%

Valuation

See full
Market cap$3.72B-0.6%

Profitability

See full
Operating margin13.1%+1.2pp
Net margin9.3%+0.3pp
FCF margin10%

Returns & leverage

See full
Return on equity14.2%0.0pp
Debt / equity0.3×0.0×
Current ratio+0.1×

Where this comes from

Reported directly by Korn Ferry in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesNoncurrent.

The official record: Korn Ferry’s 10-Q, filed March 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Korn Ferry's available-for-sale securities (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Korn Ferry's available-for-sale securities (non-current)?
Korn Ferry (KFY) reported available-for-sale securities (non-current) of $241.75M in Q4 2025.
How has Korn Ferry's available-for-sale securities (non-current) changed year-over-year?
Korn Ferry's available-for-sale securities (non-current) increased by 0.3% year-over-year, from $241.04M to $241.75M.
What is the long-term trend for Korn Ferry's available-for-sale securities (non-current)?
Over 2 years (2023 to 2025), Korn Ferry's available-for-sale securities (non-current) has grown at a 14.2% compound annual growth rate (CAGR), from $179.04M to $233.63M.